{
 "drug": "Piperacillin and Tazobactam Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/20/2026",
 "dayN": 217,
 "cat": "Anti-Infective",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/20/2026",
   "update_type": "New",
   "initial_posting_date": "01/20/2026",
   "package_ndc": "65219-434-20",
   "generic_name": "Piperacillin and Tazobactam Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA203719"
    ],
    "brand_name": [
     "PIPERACILLIN AND TAZOBACTAM"
    ],
    "generic_name": [
     "PIPERACILLIN AND TAZOBACTAM"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-434",
     "65219-436",
     "65219-259"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PIPERACILLIN SODIUM",
     "TAZOBACTAM SODIUM"
    ],
    "rxcui": [
     "1659131",
     "1659137",
     "1659149"
    ],
    "spl_id": [
     "76af03be-bc73-40f9-bde0-31fe9c359ca2"
    ],
    "spl_set_id": [
     "a798faf5-cd97-4e35-a700-94c372978c46"
    ],
    "package_ndc": [
     "65219-434-02",
     "65219-434-20",
     "65219-436-02",
     "65219-436-20",
     "65219-259-05",
     "65219-259-45"
    ],
    "unii": [
     "UXA545ABTT",
     "M98T69Q7HP"
    ]
   },
   "update_date": "01/20/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}